Wockhardt Ltd

NSE: WOCKPHARMA · BSE: 532300 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹2,034.60
Market cap: ₹33,065 Cr
Revenue (annual): ₹3,373 Cr
Net profit (annual): ₹213.0 Cr
P/E (TTM): 80.7×Sector 43.8×
Promoter holding: 49.32%+0.24% QoQ
FII holding: 7.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Board Meeting Date 6 Financial Results 4 Annual General Meeting 4 Management Change 3 Results Update 2 Legal & Regulatory 2 Earnings Call 2 Business Update 2 Regulatory Approval 1 Fund Raise 1 Employee Stock Options 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 May 2026 18:44 IST BSE

Fund Raise

Wockhardt Fund Raise of ₹977.8 Cr

Wockhardt Limited filed its quarterly Monitoring Agency Report for the QIP proceeds. As of March 31, 2026, the company utilized ₹815.46 Crore out of ₹977.79 Crore net proceeds. The Board extended the utilization timeline for the remaining ₹162.33 Crore, earmarked for R&D and capital expenditure, until financial year 2028.

Value: ₹977.8 Cr
Execution: Up to financial year 2028

Open announcement → Read the filing ↗